Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Cell Biochem. 2011 Jul;112(7):1737–1748. doi: 10.1002/jcb.23093

Fig 4.

Fig 4

Silencing of C/EBPβ with C/EBPβ siRNA inhibits dexamethasone-induced C/EBPβ and atrogin-1 expression and protein degradation in cultured L6 myotubes. L6 myotubes were transfected with non-targeting or C/EBPβ siRNA followed by treatment with 1 µM dexamethasone for 24 h and determination of (A) C/EBPβ protein levels, (B) atrogin-1 mRNA levels, (C) MuRF1 mRNA levels, and (D) protein degradation rates. Results are means ± SEM with n≥6 per group. *p<0.05 vs –Dex; +p<0.05 vs corresponding non-targeting group by ANOVA.